Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Longer-term direct and indirect effects of infant rotavirus vaccination across all ages in the US; 2000 - 2013: analysis of a large hospital discharge dataset.

Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA.

Clin Infect Dis. 2018 Jul 18. doi: 10.1093/cid/ciy580. [Epub ahead of print]

PMID:
30020438
2.

A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness.

Haber M, Lopman BA, Tate JE, Shi M, Parashar UD.

Vaccine. 2018 Jul 3. pii: S0264-410X(18)30923-X. doi: 10.1016/j.vaccine.2018.06.072. [Epub ahead of print]

PMID:
29980389
3.

Burden of Severe Norovirus Disease in Taiwan, 2003-2013.

Burke RM, Shih SM, Yen C, Huang YC, Parashar UD, Lopman BA, Wu FT, Hsiung CA, Hall AJ.

Clin Infect Dis. 2018 Jun 6. doi: 10.1093/cid/ciy298. [Epub ahead of print]

PMID:
29878104
4.

Evaluating Previous Antibiotic Use as a Risk Factor for Acute Gastroenteritis Among Children in Davidson County, Tennessee, 2014-2015.

Kolsin JM, Lopman BA, Payne DC, Wikswo ME, Dunn JR, Halasa NB, Hall AJ.

J Pediatric Infect Dis Soc. 2018 May 19. doi: 10.1093/jpids/piy044. [Epub ahead of print]

PMID:
29788403
5.

Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.

Tate JE, Mwenda JM, Armah G, Jani B, Omore R, Ademe A, Mujuru H, Mpabalwani E, Ngwira B, Cortese MM, Mihigo R, Glover-Addy H, Mbaga M, Osawa F, Tadesse A, Mbuwayesango B, Simwaka J, Cunliffe N, Lopman BA, Weldegebriel G, Ansong D, Msuya D, Ogwel B, Karengera T, Manangazira P, Bvulani B, Yen C, Zawaira FR, Narh CT, Mboma L, Saula P, Teshager F, Getachew H, Moeti RM, Eweronu-Laryea C, Parashar UD; African Intussusception Surveillance Network.

N Engl J Med. 2018 Apr 19;378(16):1521-1528. doi: 10.1056/NEJMoa1713909.

PMID:
29669224
6.

Rotavirus Vaccines and Health Care Utilization for Diarrhea in US Children, 2001-2015.

Getachew HB, Dahl RM, Lopman BA, Parashar UD.

Pediatr Infect Dis J. 2018 Mar 14. doi: 10.1097/INF.0000000000001988. [Epub ahead of print]

PMID:
29561514
7.

Annual changes in rotavirus hospitalization rates before and after rotavirus vaccine implementation in the United States.

Shah MP, Dahl RM, Parashar UD, Lopman BA.

PLoS One. 2018 Feb 14;13(2):e0191429. doi: 10.1371/journal.pone.0191429. eCollection 2018.

8.

Waxing Understanding of Waning Immunity.

Lopman BA, Pitzer VE.

J Infect Dis. 2018 Mar 5;217(6):851-853. doi: 10.1093/infdis/jix670. No abstract available.

PMID:
29394364
9.

Temporal Relationship Between Healthcare-Associated and Nonhealthcare-Associated Norovirus Outbreaks and Google Trends Data in the United States.

Osuka H, Hall AJ, Wikswo ME, Baker JM, Lopman BA.

Infect Control Hosp Epidemiol. 2018 Mar;39(3):355-358. doi: 10.1017/ice.2017.322. Epub 2018 Jan 31.

PMID:
29382406
10.

The unwelcome houseguest: secondary household transmission of norovirus.

Marsh ZA, Grytdal SP, Beggs JC, Leshem E, Gastañaduy PA, Rha B, Nyaku M, Lopman BA, Hall AJ.

Epidemiol Infect. 2018 Jan;146(2):159-167. doi: 10.1017/S0950268817002783. Epub 2017 Dec 12.

11.

Causes of impaired oral vaccine efficacy in developing countries.

Parker EP, Ramani S, Lopman BA, Church JA, Iturriza-Gómara M, Prendergast AJ, Grassly NC.

Future Microbiol. 2018 Jan;13:97-118. doi: 10.2217/fmb-2017-0128. Epub 2017 Dec 8. Review.

12.

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

Burnett E, Lopman BA, Parashar UD.

Vaccine. 2017 Dec 18;35(51):7198-7203. doi: 10.1016/j.vaccine.2017.10.027. Epub 2017 Nov 20.

PMID:
29169893
13.

National Estimates of Reductions in Acute Gastroenteritis-Related Hospitalizations and Associated Costs in US Children After Implementation of Rotavirus Vaccines.

Leshem E, Tate JE, Steiner CA, Curns AT, Lopman BA, Parashar UD.

J Pediatric Infect Dis Soc. 2017 Aug 10. doi: 10.1093/jpids/pix057. [Epub ahead of print]

PMID:
28992205
14.

Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies.

Lewnard JA, Lopman BA, Parashar UD, Bar-Zeev N, Samuel P, Guerrero ML, Ruiz-Palacios GM, Kang G, Pitzer VE.

J Infect Dis. 2017 Aug 1;216(3):317-326. doi: 10.1093/infdis/jix310.

PMID:
28859432
15.

Parenteral protein-based rotavirus vaccine.

O'Ryan M, Lopman BA.

Lancet Infect Dis. 2017 Aug;17(8):786-787. doi: 10.1016/S1473-3099(17)30244-X. Epub 2017 May 5. No abstract available.

16.

Use of Internet Search Data to Monitor Rotavirus Vaccine Impact in the United States, United Kingdom, and Mexico.

Shah MP, Lopman BA, Tate JE, Harris J, Esparza-Aguilar M, Sanchez-Uribe E, Richardson V, Steiner CA, Parashar UD.

J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):56-63. doi: 10.1093/jpids/pix004.

PMID:
28369477
17.

Assessment of the Status of Measles Elimination in the United States, 2001-2014.

Gastañaduy PA, Paul P, Fiebelkorn AP, Redd SB, Lopman BA, Gambhir M, Wallace GS.

Am J Epidemiol. 2017 Apr 1;185(7):562-569. doi: 10.1093/aje/kww168.

PMID:
28338902
18.

Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options.

Steele MK, Remais JV, Gambhir M, Glasser JW, Handel A, Parashar UD, Lopman BA.

Epidemics. 2016 Dec;17:42-49. doi: 10.1016/j.epidem.2016.10.006. Epub 2016 Oct 24.

19.

Strain-Specific Virolysis Patterns of Human Noroviruses in Response to Alcohols.

Park GW, Collins N, Barclay L, Hu L, Prasad BV, Lopman BA, Vinjé J.

PLoS One. 2016 Jun 23;11(6):e0157787. doi: 10.1371/journal.pone.0157787. eCollection 2016.

20.

Global Economic Burden of Norovirus Gastroenteritis.

Bartsch SM, Lopman BA, Ozawa S, Hall AJ, Lee BY.

PLoS One. 2016 Apr 26;11(4):e0151219. doi: 10.1371/journal.pone.0151219. eCollection 2016.

21.

The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control.

Lopman BA, Steele D, Kirkwood CD, Parashar UD.

PLoS Med. 2016 Apr 26;13(4):e1001999. doi: 10.1371/journal.pmed.1001999. eCollection 2016 Apr. Review.

22.

Incidence of Norovirus-Associated Medical Encounters among Active Duty United States Military Personnel and Their Dependents.

Rha B, Lopman BA, Alcala AN, Riddle MS, Porter CK.

PLoS One. 2016 Apr 26;11(4):e0148505. doi: 10.1371/journal.pone.0148505. eCollection 2016.

23.

Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies.

Tate JE, Patel MM, Cortese MM, Payne DC, Lopman BA, Yen C, Parashar UD.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S106-14. doi: 10.1093/cid/civ1014.

PMID:
27059343
24.

Editorial Commentary: Pediatric Norovirus in Developing Countries: A Picture Slowly Comes Into Focus.

Lopman BA, Grassly NC.

Clin Infect Dis. 2016 May 15;62(10):1218-20. doi: 10.1093/cid/ciw078. Epub 2016 Mar 24. No abstract available.

PMID:
27013691
25.

Norovirus in 2016-Emesis Aplenty but Clear Signs of Progress.

Head MG, Lopman BA.

J Infect Dis. 2016 Feb 1;213 Suppl 1:S1-2. doi: 10.1093/infdis/jiv409.

PMID:
26744425
26.

Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis.

Kambhampati A, Payne DC, Costantini V, Lopman BA.

Clin Infect Dis. 2016 Jan 1;62(1):11-18. doi: 10.1093/cid/civ873. Epub 2015 Oct 26. Review.

27.

Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Aliabadi N, Lopman BA, Parashar UD, Hall AJ.

Expert Rev Vaccines. 2015;14(9):1241-53. doi: 10.1586/14760584.2015.1073110. Epub 2015 Jul 29. Review.

28.

Acute gastroenteritis hospitalizations among US children following implementation of the rotavirus vaccine.

Leshem E, Tate JE, Steiner CA, Curns AT, Lopman BA, Parashar UD.

JAMA. 2015 Jun 9;313(22):2282-4. doi: 10.1001/jama.2015.5571. No abstract available. Erratum in: JAMA. 2015 Jul 14;314(2):188.

PMID:
26057291
29.

Global age distribution of pediatric norovirus cases.

Shioda K, Kambhampati A, Hall AJ, Lopman BA.

Vaccine. 2015 Aug 7;33(33):4065-8. doi: 10.1016/j.vaccine.2015.05.051. Epub 2015 Jun 4.

30.

Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.

Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J.

Lancet Infect Dis. 2015 Jun;15(6):703-10. doi: 10.1016/S1473-3099(15)70139-8. Epub 2015 Apr 14.

31.

Burden of norovirus in healthcare facilities and strategies for outbreak control.

Kambhampati A, Koopmans M, Lopman BA.

J Hosp Infect. 2015 Apr;89(4):296-301. doi: 10.1016/j.jhin.2015.01.011. Epub 2015 Feb 4. Review.

32.

Norovirus Infection and Disease in an Ecuadorian Birth Cohort: Association of Certain Norovirus Genotypes With Host FUT2 Secretor Status.

Lopman BA, Trivedi T, Vicuña Y, Costantini V, Collins N, Gregoricus N, Parashar U, Sandoval C, Broncano N, Vaca M, Chico ME, Vinjé J, Cooper PJ.

J Infect Dis. 2015 Jun 1;211(11):1813-21. doi: 10.1093/infdis/jiu672. Epub 2014 Dec 10.

33.

Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.

Payne DC, Parashar UD, Lopman BA.

Curr Opin Pediatr. 2015 Feb;27(1):105-9. doi: 10.1097/MOP.0000000000000166. Review.

34.

Reduced rotavirus vaccine effectiveness among children born during the rotavirus season: a pooled analysis of 5 case-control studies from the Americas.

Premkumar PS, Parashar UD, Gastanaduy PA, McCracken JP, de Oliveira LH, Payne DC, Patel MM, Tate JE, Lopman BA.

Clin Infect Dis. 2015 Apr 1;60(7):1075-8. doi: 10.1093/cid/ciu956. Epub 2014 Dec 1.

PMID:
25452592
35.

Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis.

Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, Koopmans M, Lopman BA.

Lancet Infect Dis. 2014 Aug;14(8):725-730. doi: 10.1016/S1473-3099(14)70767-4. Epub 2014 Jun 26. Review.

PMID:
24981041
36.

The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection.

Belliot G, Lopman BA, Ambert-Balay K, Pothier P.

Clin Microbiol Infect. 2014 Aug;20(8):724-30. doi: 10.1111/1469-0691.12722. Review.

37.

Rotavirus vaccines and health care utilization for diarrhea in the United States (2007-2011).

Leshem E, Moritz RE, Curns AT, Zhou F, Tate JE, Lopman BA, Parashar UD.

Pediatrics. 2014 Jul;134(1):15-23. doi: 10.1542/peds.2013-3849. Epub 2014 Jun 9.

38.

Rotavirus vaccines: current status and future considerations.

Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD.

Hum Vaccin Immunother. 2014;10(6):1436-48. doi: 10.4161/hv.28857. Epub 2014 Apr 22. Review.

39.

Fitting outbreak models to data from many small norovirus outbreaks.

O'Dea EB, Pepin KM, Lopman BA, Wilke CO.

Epidemics. 2014 Mar;6:18-29. doi: 10.1016/j.epidem.2013.12.002. Epub 2014 Jan 8.

40.

Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.

Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD.

Expert Rev Vaccines. 2014 Mar;13(3):365-76. doi: 10.1586/14760584.2014.877846. Epub 2014 Jan 6. Review.

PMID:
24392657
41.

The development of Web-based surveillance provides new insights into the burden of norovirus outbreaks in hospitals in England.

Harris JP, Adams NL, Lopman BA, Allen DJ, Adak GK.

Epidemiol Infect. 2014 Aug;142(8):1590-8. doi: 10.1017/S0950268813002896. Epub 2013 Nov 14.

PMID:
24230984
42.

A systematic review and meta-analysis of the global seasonality of norovirus.

Ahmed SM, Lopman BA, Levy K.

PLoS One. 2013 Oct 2;8(10):e75922. doi: 10.1371/journal.pone.0075922. eCollection 2013. Review.

43.

Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination.

Gastañaduy PA, Curns AT, Parashar UD, Lopman BA.

JAMA. 2013 Aug 28;310(8):851-3. doi: 10.1001/jama.2013.170800. No abstract available.

PMID:
23982372
44.

Linking time-varying symptomatology and intensity of infectiousness to patterns of norovirus transmission.

Zelner JL, Lopman BA, Hall AJ, Ballesteros S, Grenfell BT.

PLoS One. 2013 Jul 24;8(7):e68413. doi: 10.1371/journal.pone.0068413. Print 2013.

45.

Emergency department visit data for rapid detection and monitoring of norovirus activity, United States.

Rha B, Burrer S, Park S, Trivedi T, Parashar UD, Lopman BA.

Emerg Infect Dis. 2013 Aug;19(8):1214-21. doi: 10.3201/eid1908.130483.

46.

Norovirus disease in the United States.

Hall AJ, Lopman BA, Payne DC, Patel MM, Gastañaduy PA, Vinjé J, Parashar UD.

Emerg Infect Dis. 2013 Aug;19(8):1198-205. doi: 10.3201/eid1908.130465.

47.

Does spatial proximity drive norovirus transmission during outbreaks in hospitals?

Harris JP, Lopman BA, Cooper BS, O'Brien SJ.

BMJ Open. 2013 Jul 13;3(7). pii: e003060. doi: 10.1136/bmjopen-2013-003060. Print 2013. Erratum in: BMJ Open. 2013;3(8):e003060corr1.

48.

Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012.

Tate JE, Haynes A, Payne DC, Cortese MM, Lopman BA, Patel MM, Parashar UD.

Pediatr Infect Dis J. 2013 Jul;32(7):741-4. doi: 10.1097/INF.0b013e31828d639c.

PMID:
23426425
49.

Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009.

Gastañaduy PA, Hall AJ, Curns AT, Parashar UD, Lopman BA.

J Infect Dis. 2013 Apr;207(7):1058-65. doi: 10.1093/infdis/jis942. Epub 2013 Jan 8.

PMID:
23300161
50.

Clinical characteristics of norovirus-associated deaths: a systematic literature review.

Trivedi TK, Desai R, Hall AJ, Patel M, Parashar UD, Lopman BA.

Am J Infect Control. 2013 Jul;41(7):654-7. doi: 10.1016/j.ajic.2012.08.002. Epub 2012 Dec 21. Review.

PMID:
23266383

Supplemental Content

Loading ...
Support Center